Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-13 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |